The cholangitis infection is often caused by bacteria, a gallstone or any another blockage. Primary biliary cholangitis is a chronic condition where inflammation of the bile duct system keeps bile ...
Statin use in patients with primary biliary cholangitis is linked to lower risks for hepatic decompensation and major adverse liver outcomes.
A primary biliary cholangitis (PBC) diagnosis can be life-changing. For many, it’s an emotional journey filled with questions, uncertainties and a need to redefine what life looks like with a chronic ...
A new study published in the journal of Hepatology showed that statin usage was linked to decreased risks of significant ...
Elafibranor, a dual peroxisome proliferator-activated receptor (PPAR) alpha and delta agonist, appears to be a safe and effective treatment of primary biliary cholangitis, according to a new clinical ...
Primary biliary cholangitis (PBC) and Primary sclerosing cholangtiis (PSC) are both progressive bile duct-related liver diseases, with similar symptoms and effects. Both diseases cause the gradual ...
EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for primary biliary cholangitis (PBC) has undergone a marked transformation over the past year, driven by the recent approvals of ...
While PBC progresses slowly and many patients do not experience symptoms during the early stages of disease, there are many symptoms to look out for. In later stages of disease, patients may ...
Primary biliary cholangitis (PBC) is a chronic cholestatic disorder in which symptoms exert a direct influence on patients’ quality of life. Beyond pruritus and fatigue, patients with PBC are also ...
Acute cholangitis is a severe, bacterial infection of the biliary tract precipitated by an obstruction that often results in systemic inflammation and, in some cases, life‐threatening sepsis. This ...
FDA on Wednesday restricted the use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) due to the risk of serious liver injury in patients with advanced cirrhosis. Serious side effects ...
Introduction: Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease. Despite established first-line therapy with ursodeoxycholic acid (UDCA), many patients do not achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results